ACRS
Price
$2.10
Change
+$0.03 (+1.45%)
Updated
Sep 5 closing price
Capitalization
227.5M
60 days until earnings call
ANIK
Price
$8.94
Change
-$0.15 (-1.65%)
Updated
Sep 5 closing price
Capitalization
128.9M
54 days until earnings call
Interact to see
Advertisement

ACRS vs ANIK

Header iconACRS vs ANIK Comparison
Open Charts ACRS vs ANIKBanner chart's image
Aclaris Therapeutics
Price$2.10
Change+$0.03 (+1.45%)
Volume$749.21K
Capitalization227.5M
Anika Therapeutics
Price$8.94
Change-$0.15 (-1.65%)
Volume$67.47K
Capitalization128.9M
ACRS vs ANIK Comparison Chart in %
Loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRS vs. ANIK commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Buy and ANIK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ACRS: $2.10 vs. ANIK: $8.94)
Brand notoriety: ACRS and ANIK are both not notable
ACRS represents the Biotechnology, while ANIK is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACRS: 74% vs. ANIK: 47%
Market capitalization -- ACRS: $227.5M vs. ANIK: $128.9M
ACRS [@Biotechnology] is valued at $227.5M. ANIK’s [@Pharmaceuticals: Generic] market capitalization is $128.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileANIK’s FA Score has 0 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • ANIK’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRS is a better buy in the long-term than ANIK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 4 TA indicator(s) are bullish while ANIK’s TA Score has 3 bullish TA indicator(s).

  • ACRS’s TA Score: 4 bullish, 4 bearish.
  • ANIK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACRS is a better buy in the short-term than ANIK.

Price Growth

ACRS (@Biotechnology) experienced а +8.81% price change this week, while ANIK (@Pharmaceuticals: Generic) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ACRS is expected to report earnings on Nov 05, 2025.

ANIK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($227M) has a higher market cap than ANIK($129M). ACRS YTD gains are higher at: -15.323 vs. ANIK (-45.687). ANIK has higher annual earnings (EBITDA): -2.24M vs. ACRS (-57.87M). ACRS has more cash in the bank: 99.8M vs. ANIK (53.2M). ANIK has higher revenues than ACRS: ANIK (115M) vs ACRS (16.8M).
ACRSANIKACRS / ANIK
Capitalization227M129M176%
EBITDA-57.87M-2.24M2,581%
Gain YTD-15.323-45.68734%
P/E RatioN/AN/A-
Revenue16.8M115M15%
Total Cash99.8M53.2M188%
Total DebtN/A25M-
FUNDAMENTALS RATINGS
ACRS vs ANIK: Fundamental Ratings
ACRS
ANIK
OUTLOOK RATING
1..100
2880
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
3865
P/E GROWTH RATING
1..100
10074
SEASONALITY SCORE
1..100
5029

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACRS's Valuation (24) in the Pharmaceuticals Other industry is significantly better than the same rating for ANIK (92). This means that ACRS’s stock grew significantly faster than ANIK’s over the last 12 months.

ACRS's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ANIK (100). This means that ACRS’s stock grew similarly to ANIK’s over the last 12 months.

ANIK's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as ACRS (99). This means that ANIK’s stock grew similarly to ACRS’s over the last 12 months.

ACRS's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as ANIK (65). This means that ACRS’s stock grew similarly to ANIK’s over the last 12 months.

ANIK's P/E Growth Rating (74) in the Pharmaceuticals Other industry is in the same range as ACRS (100). This means that ANIK’s stock grew similarly to ACRS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACRSANIK
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 9 days ago
63%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAIDF12.510.70
+5.93%
Baidu, Inc.
CUYTF44.10N/A
N/A
COLRUYT GROUP N.V.
DQWS0.03N/A
N/A
Dswiss Inc
TRVR35.00N/A
N/A
Two Rivers Financial Group, Inc.
PHCCF7.05N/A
N/A
PHC Holdings Corp.

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with PLLWF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then PLLWF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+1.45%
PLLWF - ACRS
64%
Loosely correlated
N/A
MYNZ - ACRS
40%
Loosely correlated
-2.98%
UFPT - ACRS
39%
Loosely correlated
-0.75%
IBRX - ACRS
34%
Loosely correlated
+0.42%
ANIK - ACRS
34%
Loosely correlated
-1.65%
More

ANIK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with RVTY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
-1.65%
RVTY - ANIK
39%
Loosely correlated
+1.10%
AVNS - ANIK
35%
Loosely correlated
+0.47%
ACRS - ANIK
34%
Loosely correlated
+1.45%
ORGO - ANIK
33%
Poorly correlated
-0.60%
FLGT - ANIK
32%
Poorly correlated
-0.14%
More